Acute toxicity in 260 patients with locally limited prostate cancer after conformal radiotherapy risk-adjusted up to 74 Gy:: Results of a multicenter phase-II study

被引：0
|
作者：
Zimmermann, F
Geinitz, H
Wachter, S
Wachter-Gerstner, N
Goldner, G
Glocker, S
Feldmann, HJ
Becker, G
Bamberg, M
Pötter, R
Molls, M
机构：
[1] Tech Univ Munich, Klin Strahlentherapie & Radiol Onkol, D-8000 Munich, Germany
[2] Univ Vienna, Klin Strahlentherapie & Biol, Vienna, Austria
[3] Univ Klin Tubingen, Abt Strahlentherapie Radiol, D-72074 Tubingen, Germany
[4] Klinikum Fulda, Klin Radioonkol Strahlentherapie, Fulda, Germany
[5] Klin Eichert Goppingen, Onkol Klin, Strahlentherapie Radiol Zent Inst, Goppingen, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2002年 / 178卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：21 / 21
页数：1
相关论文
共 40 条
  • [21] Preliminary results of late rectal and urinary toxicity in a phase II randomized study of conventional fractionation vs. hypofractionation on patients with high risk prostate cancer
    Gomellini, S.
    Petrongari, M. G.
    Saracino, B. M.
    Arcangeli, S.
    Marzi, S.
    Landoni, V.
    Benassi, M.
    Sperduti, I.
    Arcangeli, G.
    EJC SUPPLEMENTS, 2007, 5 (04): : 289 - 289
  • [22] MULTICENTRE PHASE I/II STUDY OF HYPO-FRACTIONATED IMAGE-GUIDED RADIOTHERAPY (55 GY/16 FRACTIONS/4 WEEKS) FOR LOW AND INTERMEDIATE RISK PROSTATE CANCER: TOXICITY REPORT AT 24-MONTH FOLLOW-UP
    Wu, J. S. Y.
    El-Gayed, A.
    Pervez, N.
    Tai, P.
    Skarsgard, D.
    Sia, M.
    Brasher, P.
    Joseph, K.
    Pearcey, R.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S30 - S31
  • [23] ACUTE AND SUBACUTE GASTROINTESTINAL AND GENITOURINARY TOXICITY PROFILES OF METFORMIN VERSUS PLACEBO PLUS PROSTATE AND PELVIC RADIOTHERAPY FOR THE MANAGEMENT OF HIGH RISK PROSTATE CANCER: INTERIM TOXICITY RESULTS OF A DOUBLE-BLINDED, MULTICENTRE, PHASE II RANDOMIZED CONTROLLED TRIAL
    McDonald, Megan O.
    Usmani, Nawaid
    Ong, Aldrich
    Koul, Rashmi
    Dubey, Arbind
    Ahmed, Shahida
    Quon, Harvey
    Yee, Don
    Parliament, Matthew
    Sivananthan, Gokulan
    Danielson, Brita
    Rowe, Lindsay
    Rose, James
    Hunter, William
    Sanghera, Karan Paul
    Ghosh, Sunita
    Kim, Julian O.
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S4 - S5
  • [24] The acute toxicity results of the GETUG-AFU 22 study: A multicenter randomized phase II trial comparing the efficacy of a short hormone therapy in combination with radiotherapy to radiotherapy alone as a salvage treatment for patients with detectable PSA after radical prostatectomy.
    Guerif, Stephane Gilles
    Latorzeff, Igor
    Roca, Lise
    Allouache, Djelila
    Supiot, Stephane
    Lagneau, Edouard
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [25] Stereotactic body radiotherapy (SBRT) versus conventional fractionated intensity-modulated radiotherapy (CF-IMRT) for Asian patients with early-stage localized prostate cancer: Acute toxicity results from a prospective randomized phase II study
    Poon, D. M.
    Lam, D.
    Wong, K.
    Mok, F.
    Mo, F.
    Chu, C. M.
    Ng, A. C. F.
    Suen, J.
    Chan, A. T. C.
    ANNALS OF ONCOLOGY, 2018, 29
  • [26] Phase I/II study of stereotactic ablative radiotherapy including regional lymph node irradiation for patients with high-risk prostate cancer (SATURN): Early results.
    Musunuru, Hima Bindu
    D'Alimonte, Laura
    Davidson, Melanie
    Ho, Ling
    Cheung, Patrick
    Vesprini, Danny
    Liu, Stanley K.
    Chu, William
    Chung, Hans T.
    Ravi, Ananth
    Deabreu, Andrea
    Bhounr, Zeeba
    Zhang, Liying
    Commissso, Kristina
    Loblaw, Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [27] Proctitis after external-beam radiotherapy for prostate cancer classified by Vienna Rectoscopy Score and correlated with EORTC/RTOG score for late rectal toxicity:: Results of a prospective multicenter study of 166 patients
    Goldner, Gregor
    Tomicek, Birgit
    Becker, Gerd
    Geinitz, Hans
    Wachter, Stefan
    Zimmermann, Frank
    Wachter-Gerstner, Natascha
    Reibenwein, Jochen
    Glocker, Stefan
    Bamberg, Michael
    Feldmann, Horst
    Poetzi, Regina
    Molls, Michael
    Poetter, Rochard
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 67 (01): : 78 - 83
  • [28] 1056 PRELIMINARY RESULTS OF LATE RECTAL AND URINARY TOXICITY IN A PHASE II RANDOMIZED STUDY OF CONVENTIONAL FRACTIONATION VS. HYPOFRACTIONATION ON PATIENTS WITH HIGH RISK PROSTATE CANCER.
    Petrongari, M. G.
    Gomellini, S.
    Saracino, B. M.
    Arcangeli, S.
    Marzi, S.
    Landoni, V.
    Strigari, L.
    Arcangeli, G.
    RADIOTHERAPY AND ONCOLOGY, 2008, 88 : S337 - S337
  • [29] A pilot multicenter phase II study of adjuvant docetaxel (D) for high risk prostate cancer (PC) patients (pts) after radical prostatectomy (RP): Preliminary data.
    Rosenbaum, E
    Kibel, A
    Roth, B
    Wilding, G
    Dreicer, R
    Chatta, G
    Petrylak, D
    Dipaula, RS
    Beer, TM
    Eisenberger, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 394S - 394S
  • [30] ACUTE AND LATE TOXICITY AFTER DOSE ESCALATION TO 82 GyE USING CONFORMAL PROTON RADIATION FOR LOCALIZED PROSTATE CANCER: INITIAL REPORT OF AMERICAN COLLEGE OF RADIOLOGY PHASE II STUDY 03-12
    Coen, John J.
    Bae, Kyounghwa
    Zietman, Anthony L.
    Patel, Baldev
    Shipley, William U.
    Slater, Jerry D.
    Rossi, Carl J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : 1005 - 1009
1234